We are a global biopharmaceutical company with the belief that everyone, everywhere deserves access to affordable quality medicines.
#SheInspires, The inspiring tales of our own Women In Science at Biocon Biologics.
Biocon’s Q4 and FY22 financial highlights.
Insulin Glargine: Journey to the historic U.S. approval for the first interchangeable biosimilar
Biocon Biologics Global Scale Capabilities